Apogee Therapeutics announced a Virtual R&D Day on December 2, 2024, to share updates on its drug candidates, including APG808 and APG777, highlighting promising trial results and future plans for asthma and atopic dermatitis treatments.
AI Assistant
APOGEE THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.